Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
0(0%)
Results Posted
125%(5 trials)
Terminated
3(38%)

Phase Distribution

Ph phase_2
2
25%
Ph not_applicable
1
13%
Ph phase_1
5
63%

Phase Distribution

5

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
5(62.5%)
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(4)
Terminated(3)
Other(1)

Detailed Status

Completed4
Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
57.1%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (62.5%)
Phase 22 (25.0%)
N/A1 (12.5%)

Trials by Status

terminated338%
unknown113%
completed450%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_1

TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)

NCT02043847
terminatedphase_2

Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

NCT00096460
completedphase_2

Autologous Transplant in HIV Patients (BMT CTN 0803)

NCT01141712
unknownnot_applicable

Study of the Therapeutic Effects of Cortical Autograft Implantation in Patients With Cerebral Ischemia

NCT04488965
terminatedphase_1

Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma

NCT02043860
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02043847Phase 1

TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)

Completed
NCT00096460Phase 2

Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

Terminated
NCT01141712Phase 2

Autologous Transplant in HIV Patients (BMT CTN 0803)

Completed
NCT04488965Not Applicable

Study of the Therapeutic Effects of Cortical Autograft Implantation in Patients With Cerebral Ischemia

Unknown
NCT02043860Phase 1

Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma

Terminated
NCT00024466Phase 1

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Completed
NCT02353572Phase 1

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Terminated
NCT01112189Phase 1

Use of Stem Cells in Lymphedema Post Mastectomy

Completed

All 8 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
8